• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND ARCHITECT AFP REAGENT KIT; KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND ARCHITECT AFP REAGENT KIT; KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS Back to Search Results
Catalog Number 03P36-31
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/28/2021
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Was this device serviced by a third party? no.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.(b)(6).All available patient information was included.Additional patient details are not available.
 
Event Description
The customer observed a falsely elevated architect afp result for one patient.The following data was provided: initial result was 40.98, repeat was 3.4 ng/ml.The patient¿s previous result was 3.3 ng/ml.There was no impact to patient management reported.
 
Manufacturer Narrative
The complaint investigation for falsely elevated architect afp results included a search for similar complaints, review of complaint text, trending data, labeling, and device history records.Return testing was not completed as returns were not available.Using worldwide field data, the performance of reagent lot 21162fn00 and associated sublots manufactured with the same material were evaluated and are performing similar to other reagent lots in the field confirming there was no systemic issue.Trending review determined no related trend for the issue for the product.Device history record review on lot 21162fn00 did not show any potential non-conformances or deviations.Labeling was reviewed and found to adequately address the issue under review.All specifications were met indicating that the lot is performing acceptably.Based on the information provided and abbott diagnostics¿ complaint investigation, no systemic issue or deficiency of the architect afp assay, lot number 21162fn00, was identified.This follow up is being submitted to include d8 and h6 information previously submitted using the h10 section in their respective fields.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT AFP REAGENT KIT
Type of Device
KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS
Manufacturer (Section D)
ABBOTT IRELAND
finisklin business park
sligo F91VY 44
EI  F91VY44
MDR Report Key11820578
MDR Text Key281094422
Report Number3008344661-2021-00106
Device Sequence Number1
Product Code LOK
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 06/11/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/12/2021
Device Catalogue Number03P36-31
Device Lot Number21162FN00
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 04/28/2021
Initial Date FDA Received05/13/2021
Supplement Dates Manufacturer Received06/11/2021
Supplement Dates FDA Received06/11/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARC I2K PROC MOD, 03M74-01, (B)(4); ARC I2K PROC MOD, 03M74-01, (B)(4)
-
-